With box warnings

Without box warnings

Branded

Generic

4 results

oseltamivir phosphate
(Oseltamivir phosphate)
MSN LABORATORIES PRIVATE LIMITED
Usage: Oseltamivir phosphate capsules are indicated for treating acute, uncomplicated influenza A and B in patients aged 2 weeks and older, symptomatic for no more than 48 hours. They are also used for the prophylaxis of influenza in individuals 1 year and older. Annual vaccination is recommended.
rapivab
(peramivir)
BioCryst Pharmaceuticals, Inc.
Usage: RAPIVAB is indicated for treating acute uncomplicated influenza in patients aged 6 months and older when symptoms have occurred for no more than 2 days. Efficacy is mainly based on influenza A infections; limitations include potential resistance and lack of efficacy in hospitalized patients.
tamiflu
(oseltamivir phosphate)
Genentech, Inc.
Usage: TAMIFLU is indicated for treating acute, uncomplicated influenza A and B in patients 2 weeks and older within 48 hours of symptom onset, and for prophylaxis in those 1 year and older. It is not a substitute for vaccination and has limitations regarding resistance and specific patient populations.
xofluza
(BALOXAVIR MARBOXIL)
Genentech, Inc.
Usage: XOFLUZA is indicated for the treatment of acute uncomplicated influenza in patients aged 5 years and older within 48 hours of symptom onset, as well as for post-exposure prophylaxis of influenza in the same age group after contact with an infected individual.

Medications for Influenza

oseltamivir phosphate